Barry D. Quart

Companies

• Connect Biopharma Holdings LtdBoard member Mar 16, 2026 to now¹
• Connect Biopharma Holdings LtdChief executive officer Mar 16, 2026 to now¹
• Kiniksa Pharmaceuticals International, plcBoard member May 23, 2018 to now²
• HERON THERAPEUTICS, INC. /DE/Chief executive officer May 3, 2013 to Jan 20, 2023³
• HERON THERAPEUTICS, INC. /DE/Board member Jun 20, 2012 to Jan 20, 2023⁴
• HERON THERAPEUTICS, INC. /DE/President Feb 14, 2020 to Feb 14, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKiniksa Pharmaceuticals International, plc KNSA12,745 shares⁶$1.0M at $79.94Aug 19, 2026
• CBConnect Biopharma Holdings Ltd CNTB224,034 shares⁷$203.0K at $0.91Mar 16, 2026
• HTHERON THERAPEUTICS, INC. /DE/ HRTX177,989 shares⁸$67.6K at $0.38Jan 13, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 19, 2026Gift 2,600 shares of Kiniksa Pharmaceuticals International, plc⁶
• May 29, 2026Exercised options 2,799 shares of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Sold 13,099 shares at $50.10 of Kiniksa Pharmaceuticals International, plc¹⁰
• Apr 28, 2026Exercised options 13,099 shares at $14.33 of Kiniksa Pharmaceuticals International, plc¹⁰
• Apr 6, 2026Sold 6,901 shares at $50.00 of Kiniksa Pharmaceuticals International, plc¹¹
• Apr 6, 2026Exercised options 6,901 shares at $14.33 of Kiniksa Pharmaceuticals International, plc¹¹
• Feb 12, 2026Sold 2,690 shares at $45.00 of Kiniksa Pharmaceuticals International, plc¹²
• Feb 12, 2026Exercised options 2,690 shares at $15.47 of Kiniksa Pharmaceuticals International, plc¹²
• Feb 10, 2026Sold 110 shares at $45.00 of Kiniksa Pharmaceuticals International, plc¹²
• Feb 10, 2026Exercised options 110 shares at $15.47 of Kiniksa Pharmaceuticals International, plc¹²
• Feb 4, 2026Sold 2,602 shares at $45.02 of Kiniksa Pharmaceuticals International, plc¹³
• Feb 4, 2026Exercised options 2,602 shares at $15.47 of Kiniksa Pharmaceuticals International, plc¹³
• Feb 3, 2026Sold 12,528 shares at $45.27 of Kiniksa Pharmaceuticals International, plc¹³
• Feb 3, 2026Exercised options 12,528 shares at $15.47 of Kiniksa Pharmaceuticals International, plc¹³
• Feb 2, 2026Sold 830 shares at $45.00 of Kiniksa Pharmaceuticals International, plc¹³
• Feb 2, 2026Exercised options 830 shares at $15.47 of Kiniksa Pharmaceuticals International, plc¹³
• Dec 15, 2025Sold 20,129 shares at $41.51 of Kiniksa Pharmaceuticals International, plc¹⁴
• Dec 15, 2025Exercised options 20,129 shares at $10.36 of Kiniksa Pharmaceuticals International, plc¹⁴
• Jun 11, 2025Sold 12,336 shares at $30.39 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 11, 2025Exercised options 12,336 shares at $3.80 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 10, 2025Sold 8,212 shares at $30.36 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 10, 2025Exercised options 8,212 shares at $3.80 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 9, 2025Sold 6,900 shares at $30.26 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 9, 2025Exercised options 6,900 shares at $3.80 of Kiniksa Pharmaceuticals International, plc¹⁵
• Jun 5, 2025Exercised options 3,173 shares of Kiniksa Pharmaceuticals International, plc¹⁶